Document is current
Any future updates will be listed below
-
Authors
Emmanuel, Anton
Goosey, Richard William
Wiseman, Gwen
Baker, Stephen
Törnblom, Hans
-
Funding
Funding for this research was provided by:
Allergan plc (N/A)
- License Information
-
More Information
Article History
Received: 31 May 2019
Accepted: 30 March 2020
First Online: 26 April 2020
Ethics approval and consent to participate
: Ethical approval is not required because this is a market research survey per the ISPOR Code of Ethics [].However, all participants were required to review and agree to the following consent statements online before entering the survey:I understand that the information I provide is for market research purposes only.I agree to keep confidential and not use for myself or disclose to anyone else any of the content of this survey.I understand that my name will not be associated with my statements without my permission.
: Not applicable.
: AE is supported by the UCL/UCLH Biomedical Research Centre and has served on advisory boards for Allergan plc, Almirall, Shire and Takeda. RWG is an employee of Kantar Health, which received study funding from Allergan plc. GW is a former employee of Allergan plc. SB is an employee of Allergan plc. HT has served on advisory boards for Almirall, Allergan plc and Shire, and has acted as a speaker for Shire, Allergan plc, Almirall and Tillotts.
